Market Newsdesk

July 31, 2026 10:42 am

T3 Defense Inc. Subsidiaries Rimon and Tiltan Deliver Strong Year-to-Date Operating Performance

Both subsidiaries report record year-to-date revenue, new order intake, and backlog levels

NEW YORK and NETANYA, Israel, July 31, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), a defense technology holding company, today announced that its wholly owned subsidiaries Rimon and Tiltan each reported record year-to-date revenue, new orders received, and total backlog.

“With July being a milestone month for T3 Defense, both Rimon and Tiltan posted the strongest year-to-date revenue, order intake, and backlog levels. We believe that reflects the growing demand for their capabilities and the strength of the customer relationships each team has built. We remain focused on converting this momentum into durable, long-term growth across the platform,” said Menny Shalom, Chief Executive Officer of T3 Defense.

Rimon

$2.6 million revenue recorded for July 2026, an all-time monthly high
~$5.25 million in year-to-date revenue, already above full-year 2025 revenue of $4.6 million
$2.1 million backlog as of July 31, 2026, scheduled for delivery through year-end
$0.9 million in additional outstanding proposals not yet converted to orders

Rimon currently anticipates full-year 2026 revenue to exceed $7.2 million.

Rimon’s performance is driven by significant growth in activity volumes, deliveries, and orders supporting leading companies and entities in Israel’s defense industry. The growth reflects rising customer confidence in Rimon’s product quality, engineering and manufacturing capabilities, service levels, and ability to meet tight schedules and complex demands.

To support the increasing demand and an expanding project backlog, Rimon is preparing for meaningful operational expansion, hiring additional personnel, developing advanced operational systems and management software, and evaluating a move to a larger production facility to increase capacity.

Tiltan

~$1.0 million in year-to-date revenue
$2.5 million in total purchase orders received year-to-date
$1.5 million backlog, as of July 31, 2026
$3.5 million in additional outstanding proposals not yet converted to orders

Tiltan currently anticipates full-year 2026 revenue to exceed 4.0 million.

Tiltan’s performance is driven by orders from a top leading global defense customers for the development of advanced aerial sensors.

Customers selected Tiltan’s solutions after evaluating multiple alternatives, citing unique capabilities not available elsewhere for high-fidelity external-world simulation of day and thermal sensors. These systems enable customers to shorten development cycles, reduce technical risk, and lower costs by minimizing the need for extensive field testing, effectively bringing the real world into the laboratory.

About Backlog and Other Operating Metrics

* Total pipeline, as used in this release, refers to the aggregate value of proposals and quotations submitted by Rimon and Tiltan to customers that have not yet been approved, awarded, or converted into binding purchase orders or contracts as of the date indicated. Backlog is an internal operating metric, is unaudited, has not been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), and should not be construed as a guarantee of future revenue. Backlog is inherently uncertain, is subject to change (including reduction, cancellation, or non-conversion) without notice, and there can be no assurance that any portion of reported backlog will result in actual orders, revenue, or cash flow in any future period. Revenue and new order figures presented in this release are preliminary, unaudited, and subject to adjustment in connection with the Company’s regular financial closing and review procedures, including in the Company’s periodic reports filed with the U.S. Securities and Exchange Commission (the “SEC”).

About T3 Defense Inc.

T3 Defense Inc. (Nasdaq: DFNS) is a defense technology holding company pursuing an active acquisition and value-creation strategy across the defense technology sector. The Company’s wholly owned subsidiaries include Rimon, Tiltan, Nimbus, and Nukk Picolo Ltd. [Placeholder — confirm current subsidiary list and standard boilerplate language against most recent SEC filings.]

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Forward-looking statements are statements that are not historical facts and may include statements regarding the Company’s expectations, beliefs, plans, or intentions, including statements regarding anticipated future revenue, orders, backlog conversion, growth trends, and the future performance of Rimon, Tiltan, and the Company’s other subsidiaries. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

These forward-looking statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation: the fact that reported backlog consists of unapproved proposals that may not convert into binding orders or revenue; the risk that record monthly results may not be indicative of future or sustained performance; risks associated with the Company’s liquidity, capital resources, and ability to access funding under its equity line of credit facility; risks relating to the Company’s pending and future acquisitions, dispositions, and corporate restructuring transactions; competitive, regulatory, and geopolitical conditions affecting the defense sector, including conditions in Israel; the Company’s ability to maintain compliance with Nasdaq listing requirements; and other risks and uncertainties described in the Company’s filings with the SEC, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact Us:

T3 Defense Inc.

575 5^th Avenue
New York, NY 10017
[email protected]
www.t3dfns.com

Investor Relations

The Equity Group Inc.
Lena Cati
[email protected]
+1 212 836-9611

Val Ferraro
[email protected]
+1 212 836-9612

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5608a898-3bd3-4548-bbda-16416e860d43

July 31, 2026 10:41 am

BFC PARTNERS AND SAA CANOPY GROUP CLOSE ON $269M CONSTRUCTION LOAN FOR MAJOR RENOVATION OF PARKSIDE COMMONS IN SYRACUSE, NEW YORK

PR Newswire

Joint Venture Takes on
Extensive Renovations and New Construction, Transforming Quality of Life for Residents an
d Revitalizing Syracuse’s East Side

SYRACUSE, N.Y., July 31, 2026 /PRNewswire/ — BFC Partners and SAA Canopy Group have closed on a $269 million construction loan to transform the long-standing Parkside Commons housing complex on Syracuse’s East Side. The project will deliver a total of 393 affordable apartments through a combination of renovated and newly constructed housing, significantly upgrading living conditions across the property while opening additional land for future development. This transformative investment reflects BFC Partners’ and SAA Canopy’s shared commitment to revitalizing communities and setting a new standard for quality, sustainable housing in Syracuse.

“Our mission at BFC is to create high-quality affordable housing that enhances the quality of life for the families who call our communities home,” said Winthrop Wharton, Principal, BFC Partners. “Parkside Commons is poised for a transformative new chapter, and we are proud to partner with New York State to deliver the substantial investments this community deserves. Together, we are not just preserving affordable housing. We are modernizing residents’ homes, and creating a safer, more vibrant community where families can thrive for generations to come.”

“For decades, we’ve been building and preserving housing across New York State, and Parkside Commons reflects everything we’ve learned about doing it right — keeping residents rooted in their community while fundamentally upgrading the homes they live in,” said David Alexander, Co-Managing Partner of SAA Canopy Group. “As we begin this work under the SAA Canopy name, our commitment is the same as it’s been from the start: quality homes, strong neighborhoods, enhanced living environments, and continued affordability.”

The property currently consists of 10 buildings spanning Westmoreland and East Fayette Streets, and the loan will enable BFC Partners and SAA Canopy to simultaneously renovate six of those buildings and construct two new ones. The new buildings will provide enough space to relocate every current resident of the four oldest structures on the site, which will then be demolished. Once that land is cleared, it will become the site of additional housing in a later development phase, with BFC Partners and SAA Canopy planning to work with city planners and community members on options for the site. This will occur once construction on the current phase is underway.

Construction is expected to begin in September. Renovations to the six western buildings, accounting for 200 apartments, are targeted for completion by early 2028. At the corner of Westmoreland and East Fayette Streets, two new structures, four and five stories tall, totaling 193 units, are expected to be ready for occupancy by late 2028.

“Strong communities begin with stable, affordable homes. Every New Yorker deserves the opportunity to live in safe, quality housing that provides a foundation for families to thrive, children to succeed, and neighborhoods to grow stronger together. We are proud and thrilled to close on the first phase of our development in Syracuse, marking an important step toward creating more affordable housing and expanding opportunities for the community,” said Joseph Ferrara, Partner, BFC Partners. “This milestone reflects our shared commitment to investing in people, strengthening neighborhoods, and helping build a brighter future for New Yorkers for generations to come.”

Combining state subsidies and private investment, the project will cost $269 million. Backing the effort is a financing package from New York State Homes and Community Renewal, the State’s affordable housing agency. That package includes federal and state Low-Income Housing Tax Credits, expected to raise $88 million and $13.6 million respectively through sale to investors, along with an assortment of low-interest loans and subsidies. The remainder of the financing is provided through a $116 million construction loan from the Urban Investment Group at Goldman Sachs, interim project income generated during construction, and interest earnings on tax-exempt bond proceeds.

“Parkside Commons represents a significant investment in not only the preservation but also the creation of affordable housing in Syracuse,” said Asahi Pompey, Chair of the Urban Investment Group at Goldman Sachs. “We are proud to partner with New York State, BFC Partners, and SAA Canopy Group to deliver quality homes that will serve Syracuse families for years to come.”

“Every current resident of Parkside Commons will move into a new or fully renovated home without ever leaving their community — that’s what makes this project special,” said Connor Kenney, Co-Managing Partner of SAA Canopy Group. “We’re grateful to Governor Hochul and New York Homes and Community Renewal for their partnership, and we’re eager to get shovels in the ground this September.”

“Under Governor Hochul’s leadership, New York is prioritizing affordability. The Parkside Commons project will preserve a critical portion of Syracuse’s affordable housing stock, while also creating two modern, new buildings,” said New York State Homes and Community Renewal Commissioner RuthAnne Visnauskas. “Thanks to this $269 million investment, nearly 400 households will have safe, quality homes they can afford. We thank our project partners BFC Partners and SAA Canopy for their commitment.”

“I am very pleased that Parkside Commons has received the necessary subsidy and financing for the long-awaited redevelopment of the campus. This marks an important milestone for our community, and for the residents of Parkside Commons. This housing redevelopment investment addresses the urgent need for safe, high‑quality, affordable homes that our residents need and deserve,” said Syracuse Mayor Sharon F. Owens. “I thank Governor Hochul and our partners at New York State for their continued commitment and collaboration. Their support has been instrumental in moving this project forward, and I look forward to seeing the positive impact this development will have on our city and its future.”

“This historic $269 million investment is not just about rebuilding brick and mortar; it is a profound investment in the dignity, safety, and future of Syracuse families,” said Jimmy Monto, President Pro Tempore, Syracuse Common Council. “By transforming Parkside Commons, we are delivering on a promise to provide secure, high-quality, and deeply affordable homes that will anchor and uplift our Eastside community for generations to come.”

Located along East Fayette Street, Parkside Commons sits directly on the route of Centro’s SY 68 bus line, which connects the East Side to Downtown Syracuse’s Transit Hub and points east along Erie Boulevard. Link to additional renderings can be found here.

About BFC Partners

BFC Partners is a full-service, real estate development firm that creates community-first, urban development solutions. Since 1984, BFC has been at the forefront of developing high quality affordable, mixed-income, and market rate housing. We are dedicated to revitalizing communities and improving the lives of our residents and neighbors. As leaders in the field, our government, financial, and community partners seek us out to help start new programs and undertake complicated projects. For more information, please visit: https://www.bfcnyc.com/.

About SAA Canopy Group

SAA Canopy Group develops affordable, workforce, and mixed-income housing that strengthens communities. Drawing on five decades of development history, the firm carries forward deep expertise, enduring partnerships, and a record of disciplined execution. For more information, please visit: https://saacanopy.com/.

About the Urban Investment Group (UIG) at Goldman Sachs Alternatives

Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $500 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs.

The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.

The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors and individuals. Goldman Sachs has approximately $3.2 trillion in assets under supervision globally as of March 31, 2025.

Established in 2001, the Urban Investment Group within Goldman Sachs Asset Management has committed over $20 billion through real estate projects, social enterprises and lending facilities for small businesses and students, creating economic value and opportunities for underserved communities and families.

CONTACTS:	Barbara Wagner	Katie Prael
	Barbara Wagner Communications	Barbara Wagner Communications
	(917) 751- 4387	(646) 737 – 4600
	[email protected]	[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/bfc-partners-and-saa-canopy-group-close-on-269m-construction-loan-for-major-renovation-of-parkside-commons-in-syracuse-new-york-302840103.html

SOURCE BFC Partners

July 31, 2026 10:30 am

HELE DEADLINE: The Gross Law Firm Reminds Helen of Troy Limited Investors of Upcoming Securities Class Action Deadline

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE).

Shareholders who purchased shares of HELE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=197220&from=3

CLASS PERIOD: April 24, 2024 to October 8, 2025

ALLEGATIONS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that evidence suggests that given the importance of project pegasus to the Company’s business model and finances, the external macroeconomic conditions during the class period, and the Company’s internal budget and resource constraints, at the time these statements were made, defendants knew or should have known that project pegasus would not, and was not on track to, realize the savings, efficiency, or effectiveness that Helen of Troy consistently touted.

DEADLINE: August 3, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=197220&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HELE during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 3, 2026. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:30 am

The Gross Law Firm Reminds PROCEPT BioRobotics Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 – PRCT

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT).

Shareholders who purchased shares of PRCT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/procept-biorobotics-corporation-loss-submission-form/?id=197225&from=3

CLASS PERIOD: February 28, 2024 to February 25, 2026

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) during the class period, Procept had utilized an extensive discount program designed to incentivize its customers to place bulk orders in excess of procedure demand; (b) Procept’s undisclosed discount program had artificially and unsustainably inflated the Company’s reported U.S. handpiece unit sales and revenues by pulling forward sales at the expense of future periods; (c) Procept’s undisclosed discount program had caused customer handpiece orders to materially exceed underlying procedure demand throughout the class period and that this differential had materially grown over time; (d) Procept’s consistent surplus of U.S. handpiece unit sales relative to performed procedures had created a glut of field inventory and overstocking amongst Procept’s customer base, amounting to more than 10,000 excess units by the end of the Class Period; (e) as a result of (a)-(d) above, defendants’ representations during the class period regarding Procept’s handpiece unit sales and the utilization of Procept’s field Systems were materially overstated; (f) as a result of (a)-(e) above, Procept was acutely exposed to material undisclosed risks of significant operational and financial harm; and (g) as a result of (a)-(f) above, Procept was unable to achieve its stated 2025 handpiece sales and revenue guidance and such guidance lacked a reasonably achievable factual basis.

DEADLINE: September 22, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/procept-biorobotics-corporation-loss-submission-form/?id=197225&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of PRCT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 22, 2026. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:28 am

GRAL Shareholder Alert: GRAIL, Inc. Securities Class Action Lawsuit – Investors With Losses May Contact The Gross Law Firm

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL).

Shareholders who purchased shares of GRAL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/grail-inc-loss-submission-form/?id=197224&from=3

CLASS PERIOD: May 13, 2025 to February 19, 2026

ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of GRAIL’s NHS-Galleri trial following the reveal of the top-line results covering the first screening round. Notably, as defendants have since attested, the trial as executed within the three-year follow-up period was insufficient to demonstrate the achievability of a reduction in Stage III-IV cancers; defendants disclosed the trial period, and thus the screening duration, was apparently insufficient to demonstrate whether the primary endpoint was achievable. Defendants further repeatedly refused to provide detailed topline results or other data from the NHS-Galleri study, potentially concealing known trendlines which arguably suggested either a longer timeline would be necessary or otherwise that the probability of achieving the statistical reduction in Stage III & IV cancers by the trial’s end had been reduced. On February 19, 2026, GRAIL announced that the “primary endpoint of statistically significant Stage III-IV reduction was not observed” in the NHS-Galleri Trial. The Company attributed this shortcoming, in part, on “probably need[ing] a longer follow-up time to be able to [compare the study arms] adequately.” Following this news, the price of GRAIL’s common stock declined dramatically. From a closing market price of $101.53 per share on February 19, 2026, Grail’s stock price fell to $50.21 per share on February 20, 2026, a decline of about 50.55% in the span of just a single day.

DEADLINE: August 4, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/grail-inc-loss-submission-form/?id=197224&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of GRAL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 4, 2026. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:26 am

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA Biologics, Inc. Lawsuit – ADMA

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA).

Shareholders who purchased shares of ADMA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/adma-biologics-inc-loss-submission-form-3/?id=197227&from=3

CLASS PERIOD: August 9, 2024 to March 25, 2026

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; (4) as a result, defendants’ statements about ADMA Biologics’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: August 10, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/adma-biologics-inc-loss-submission-form-3/?id=197227&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ADMA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 10, 2026. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:26 am

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit – PODD

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Insulet Corporation (NASDAQ: PODD).

Shareholders who purchased shares of PODD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/insulet-corporation-loss-submission-form/?id=197226&from=3

CLASS PERIOD: February 21, 2025 to May 26, 2026

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Insulet’s manufacturing controls and procedures were defective; (ii) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: August 31, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/insulet-corporation-loss-submission-form/?id=197226&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of PODD during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 31, 2026. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:24 am

EMBC UPCOMING DEADLINE : The Gross Law Firm Alerts Embecta Corp. Stockholders of Securities Class Action – Contact the Firm

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Embecta Corp. (NASDAQ: EMBC).

Shareholders who purchased shares of EMBC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/embecta-corp-loss-submission-form/?id=197228&from=3

CLASS PERIOD: November 25, 2025 to May 4, 2026

ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Embecta’s fiscal results; pertinently, Embecta knew or recklessly disregarded that the Company’s guidance was misleading and unattainable. In fact, Embecta touted the Company’s pen needle business as “incredibly resolute” mere weeks prior to missing expectations and cutting 2026 fiscal guidance. On May 5, 2026, Embecta published second quarter 2026 fiscal results disclosing that the Company failed to meet its guidance for second quarter 2026 and lowered fiscal year 2026 guidance. In particular, Embecta revealed that revenue declined over 14%, much higher than the guidance of flat to a decline of 2% and that the Company was lowering estimates on US performance, largely in part due to weakness in its pen needle sales. Following this news, the price of Embecta’s common stock declined dramatically. From a closing market price of $9.25 per share on May 4, 2026, Embecta’s stock price fell to $3.90 per share on May 5, 2026, a decline of over 57.8% in a single day.

DEADLINE: August 17, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/embecta-corp-loss-submission-form/?id=197228&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of EMBC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 17, 2026. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:24 am

GTM Shareholder Alert: August 24, 2026 Lead Plaintiff Deadline in ZoomInfo Technologies Inc. Securities Class Action – Contact The Gross Law Firm

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of ZoomInfo Technologies Inc. (NASDAQ: GTM).

Shareholders who purchased shares of GTM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/zoominfo-technologies-inc-loss-submission-form-2/?id=197230&from=3

CLASS PERIOD: November 3, 2025 to May 11, 2026

DEADLINE: August 24, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/zoominfo-technologies-inc-loss-submission-form-2/?id=197230&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of GTM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 24, 2026. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

July 31, 2026 10:24 am

UniCredit, Accenture and IBM Collaborate to Build Europe’s Next-Generation Banking Platform

UniCredit, Accenture and IBM Collaborate to Build Europe’s Next-Generation Banking Platform

The partnership will establish a new technology operating model combining the resilience of mission-critical systems with the flexibility of cloud, data and artificial intelligence.

NEW YORK–(BUSINESS WIRE)–
UniCredit, one of Europe’s leading pan-European banking groups, Accenture (NYSE:ACN) and IBM have announced a long-term strategic collaboration that establishes the technology foundation supporting UniCredit’s growth across the thirteen European markets in which the Group operates.

The companies will work to design a new operating model for banking technology—one that gives UniCredit greater control over its technology evolution while combining the resilience of mission-critical systems with the flexibility of modern digital platforms, enabling continuous innovation.

As part of the agreement, Accenture will acquire from IBM the majority stake in the joint venture that currently manages a significant portion of UniCredit’s technology infrastructure. Additionally, IBM will provide modernised technology platforms to UniCredit, including IBM Z, software, and consulting. This agreement is the beginning of a multi-year programme to enhance the bank’s underlying systems and operating model.

Today’s news is part of UniCredit’s broader growth strategy and is intended to set a reference model for the next generation of banking technology in Europe, enabling faster innovation and scaling AI capabilities across the Group.

“Technology is a strategic enabler of UniCredit’s growth and transformation,” said Ali Khan, Group Digital & Information Officer, UniCredit. “Our partnership with Accenture and IBM marks an important milestone in building the next generation of our banking platform—combining the resilience our customers expect with the agility to innovate faster and scale artificial intelligence responsibly across the Group. Together, we are creating the technology foundations that will strengthen our competitiveness, support sustainable growth and deliver lasting value for our customers, colleagues and shareholders.”

“This partnership demonstrates how technology can become a strategic growth engine,” said Mauro Macchi, Chief Executive Officer of Accenture EMEA. “By bringing together a pan-European footprint, strong execution capabilities and mission-critical technology, we are creating a reinvention model built to scale across markets. Together with UniCredit, we aim to accelerate the adoption of cloud, data and artificial intelligence to unlock new sources of value, create greater value for customers, people and communities.”

“Our enhanced collaboration with UniCredit, including both our technology and consulting capabilities, reflects a shared commitment to innovation and transformation,” said Ana Paula Assis, Senior Vice President and Chair IBM EMEA & APAC. “By combining modern infrastructure with UniCredit’s hybrid cloud architecture, we are helping to establish a technology foundation that can support UniCredit’s long-term growth while delivering better experiences for its customers.”

Completion of the transaction is subject to customary closing conditions, including required regulatory approvals and applicable information and consultation procedures.

About UniCredit

UniCredit is a leading pan-European commercial bank providing best-in-class solutions and services across Italy, Germany, Austria, and Central and Eastern Europe. Our Vision is to be the Bank for Europe’s Future. Our Purpose is to Empower Communities to Progress, delivering the best-in-class products and services for all stakeholders, unleashing the potential of our people and our clients across Europe.

We serve over 20 million clients, supported by three Group product factories—Corporate, Individual and Payment Solutions—that ensure best-in-class expertise and scalable solutions across all markets. Our integrated model combines local proximity, deep client understanding and Group-wide capabilities, enabling seamless service and outstanding client experience.

Digitalisation, operational excellence and a strong commitment to ESG principles underpin our journey, helping us deliver sustainable long-term value for clients, communities, employees and shareholders.

About Accenture

Accenture helps the world’s leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed for organizations across industries. Our strategy is to be the reinvention partner of choice for our clients and lead in the safe, widespread adoption of AI, and to be the most client-focused, AI-enabled, great place to work in the world. We bring together the talent of our approximately 799,000 people with proprietary assets and platforms, deep process and industry expertise, and leading ecosystem relationships to deliver end-to-end solutions and measurable outcomes at scale. Through our Reinvention Services, we offer broad expertise across Cybersecurity, Digital Core, Finance, Industry and Enterprise, Song, Supply Chain and Engineering, and Talent, with advanced capabilities in AI and Data, Industry and Process, and Technology. We serve approximately 9,000 clients and generated approximately $70 billion in FY25 revenue. Visit us at accenture.com.

Accenture Song accelerates growth and value for our clients through sustained customer relevance. Our capabilities span ideation to execution: growth, product and experience design; technology and experience platforms; creative, media and marketing strategy; and campaign, commerce transformation content and channel orchestration. With strong client relationships and deep industry expertise, we help our clients operate at the speed of life through the unlimited potential of imagination, technology and intelligence.

About IBM

IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of governments and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM’s long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information.

Accenture Forward-Looking Statement

Except for the historical information and discussions contained herein, statements in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “likely,” “anticipates,” “aspires,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “positioned,” “outlook,” “goal,” “target” and similar expressions are used to identify these forward-looking statements. These statements are not guarantees of future performance nor promises that goals or targets will be met, and involve a number of risks, uncertainties and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or implied. These risks include, without limitation, that the collaboration might not achieve its anticipated benefits and risks and uncertainties related to the development and use of AI, including advanced AI, could harm our business, damage our reputation or give rise to legal or regulatory action, as well as the risks, uncertainties and other factors discussed under the “Risk Factors” heading in Accenture plc’s most recent Annual Report on Form 10-K and other documents filed with or furnished to the Securities and Exchange Commission. Statements in this news release speak only as of the date they were made, and Accenture undertakes no duty to update any forward-looking statements made in this news release or to conform such statements to actual results or changes in Accenture’s expectations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260731154709/en/

Armando Barone

Accenture

+39 3485608969

[email protected]

Media Relations Italy

+39 3316989467

[email protected]

KEYWORDS: New York Europe United States North America

INDUSTRY KEYWORDS: Software Banking Networks Professional Services Fintech Data Management Technology Asset Management Artificial Intelligence Security Finance Consulting

MEDIA: